Symbol="SYBX"
AssetType="Common Stock"
Name="Synlogic Inc"
Description="Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic drugs to treat cancer, inflammatory, and metabolic diseases in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1527599"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="301 BINNEY STREET, SUITE 402, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="34344400"
EBITDA="-65402000"
PERatio="None"
PEGRatio="None"
BookValue="1.238"
DividendPerShare="0"
DividendYield="0"
EPS="-0.89"
RevenuePerShareTTM="0.016"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.336"
ReturnOnEquityTTM="-0.657"
RevenueTTM="1110000"
GrossProfitTTM="1180000"
DilutedEPSTTM="-0.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.287"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="31.17"
PriceToBookRatio="0.491"
EVToRevenue="7.74"
EVToEBITDA="0.354"
Beta="0.987"
num_52WeekHigh="1.35"
num_52WeekLow="0.393"
num_50DayMovingAverage="0.508"
num_200DayMovingAverage="0.654"
SharesOutstanding="68211000"
DividendDate="2017-08-28"
ExDividendDate="None"
symbol="SYBX"
open="0.49"
high="0.54"
low="0.49"
price="0.52"
volume="54997.00"
latest_trading_day="2023-08-18"
previous_close="0.50"
change="0.02"
change_percent="4.1708%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="292522"
Change_recent_avg="-0.01"
Delta_recent_avg="0.05"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.37"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="101"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="948"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
